Business Wire

Fresenius Kabi Introduces Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL Presentations

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL presentations.
Fierce Healthcare

CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection

Astellas currently markets Adenoscan (R) (adenosine injection), the leading pharmacologic stress agent for MPI studies in the United States. Adenoscan is indicated as an adjunct to thallium-201 ...
Monthly Prescribing Reference

Fresenius Kabi Adds Additional Strengths to Adenosine Product Line

Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Fresenius Kabi announced the ...
FierceBiotech

Akorn, Inc. Announces FDA Approval of Adenosine Injection USP, 3 mg/mL

November 3 2008--LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Food and Drug Administration has granted approval for Akorn's Abbreviated New Drug ...
Monthly Prescribing Reference

Ready-to-Administer Adenosine Simplist Syringes Now Available

Fresenius Kabi announced the launch of Adenosine Injection, USP, 6mg/2mL and 12mg/4mL, in single-dose Simplist ready-to-administer prefilled syringes. Fresenius Kabi announced the launch of Adenosine ...
TCTMD

Adjunctive Intracoronary Adenosine Lessens No-Reflow in AMI Patients

A double injection of intracoronary adenosine improves myocardial reperfusion as well as early clinical outcomes in patients receiving primary percutaneous coronary intervention (PCI) for acute ...
Medscape

Selective adenosine-receptor agonist for resting perfusion scans now on the market

Deerfield, IL - The selective A 2A adenosine-receptor agonist regadenoson (Lexiscan) is now commercially available for performing resting stress-myocardial perfusion scans, announced Astellas Pharma ...
MarketWatch

Teva: FDA grants tentative approval to Adenosine injection

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Monday the Food and Drug Administration has granted tentative approval for its Adenosine injection, 3 mg/mL in 20 mL and 30 mL ...
Healio

IV, intracoronary adenosine yield identical FFR results

Fractional flow reserve measurements were similar during intravenous or intracoronary application of adenosine among patients with an intermediate degree of stenosis. Researchers systematically ...
TCTMD

Nicorandil Matches Safety, Efficacy of Adenosine in FFR Assessment

Nicorandil, a vasodilator, appears to effectively induce hyperemia during fractional flow reserve (FFR) measurement with few adverse events. The drug may prove to be a more convenient, safer ...
FierceBiotech

CV Therapeutics and Astellas Pharma Announce FDA Approval for Lexiscan Injection

PALO ALTO, Calif. and DEERFIELD, Ill., April 10 -- CV Therapeutics and Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lexiscan(TM) (regadenoson) ...